Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy using anticancer drug-resistance genes]

Y Sugimoto1

  • 1Division of Experimental Chemotherapy, Japanese Foundation for Cancer Research.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 13, 1999
PubMed
Summary

Drug-resistance gene therapy using MDR1 and MGMT genes can protect cancer patients' bone marrow cells from chemotherapy. New bicistronic vectors enhance gene therapy efficacy and safety for improved cancer treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Effects of peppermint (Mentha piperita L.) extracts on experimental allergic rhinitis in rats.

Biological & pharmaceutical bulletin·2001
Same author

The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.

Anticancer research·2001
Same author

Effects of a nitric oxide synthase inhibitor on hypophagia induced by the peripheral 5-HT receptor agonists, alpha-methyl-5-hydroxytryptamine and 5-carboxamidotryptamine in rats.

Biological & pharmaceutical bulletin·2001
Same author

Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.

Biological & pharmaceutical bulletin·2001
Same author

Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats.

Brain research·2001

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Context:

  • Myelosuppression is a critical dose-limiting toxicity in cancer chemotherapy.
  • Drug-resistance gene therapy aims to protect hematopoietic stem cells from chemotherapy agents.
  • Clinical trials for drug-resistance gene therapy are underway in the US and Japan.

Purpose:

  • To develop improved retrovirus vectors for coexpressing drug-resistance genes.
  • To enhance the efficacy and safety of chemotherapy through gene therapy.
  • To explore the use of MDR1 as an in vivo selectable marker for therapeutic gene expression.

Summary:

  • Constructed MDR1-bicistronic retrovirus vectors using Harvey murine sarcoma virus backbone and picornavirus IRES.
  • MDR1-MGMT bicistronic vectors enable coexpression of drug resistance and therapeutic genes.
  • These vectors can protect bone marrow cells from combination chemotherapy and enrich gene-modified cells.

Impact:

  • Potential to improve patient outcomes by enabling higher chemotherapy doses.
  • Offers a strategy to overcome chemotherapy-induced myelosuppression.
  • Facilitates the development of more effective and safer cancer treatment regimens.

Related Experiment Videos